Polymeric Nanoparticle Technologies for Oral Drug Delivery

Eric M. Pridgen, Frank Alexis, Omid C. Farokhzad

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

114 Citas (Scopus)


Biologics increasingly are being used for the treatment of many diseases. These treatments typically require repeated doses administered by injection. Alternate routes of administration, particularly oral, are considered favorable because of improved convenience and compliance by patients, but physiological barriers such as extreme pH level, enzyme degradation, and poor intestinal epithelium permeability limit absorption. Encapsulating biologics in drug delivery systems such as polymeric nanoparticles prevents inactivation and degradation caused by low pH and enzymes of the gastrointestinal tract. However, transport across the intestinal epithelium remains the most critical barrier to overcome for efficient oral delivery. This review focuses on recent advances in polymeric nanoparticles being developed to overcome transport barriers and their potential for translation into clinical use.

Idioma originalInglés
Páginas (desde-hasta)1605-1610
Número de páginas6
PublicaciónClinical Gastroenterology and Hepatology
EstadoPublicada - 1 oct. 2014
Publicado de forma externa


Profundice en los temas de investigación de 'Polymeric Nanoparticle Technologies for Oral Drug Delivery'. En conjunto forman una huella única.

Citar esto